Webster K. Cavenee
ORCID:0000-0003-3804-9179
发表论文 582 篇 · 总被引 89023 次 · h-index 120
代表论文
- CTNI-85. GBM AGILE PLATFORM TRIAL FOR NEWLY DIAGNOSED AND RECURRENT GBM: RESULTS OF FIRST EXPERIMENTAL ARM, REGORAFENIB (2023 · Neuro-Oncology · 被引 20)
- MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis (2023 · Proceedings of the National Academy of Sciences · 被引 15)
- A zinc transporter drives glioblastoma progression via extracellular vesicles-reprogrammed microglial plasticity (2025 · Proceedings of the National Academy of Sciences · 被引 14)
- DNA hypomethylator phenotype reprograms glutamatergic network in receptor tyrosine kinase gene-mutated glioblastoma (2024 · Acta Neuropathologica Communications · 被引 13)
- Evaluation of Regorafenib in Newly Diagnosed and Recurrent Glioblastoma: GBM AGILE Phase II/III Bayesian Randomized Platform Trial (2026 · Journal of Clinical Oncology · 被引 10)
- Noninvasive therapy of brain cancer using a unique systemic delivery methodology with a cancer terminator virus (2024 · Journal of Cellular Physiology · 被引 10)